Stockscreener 앱 받기
5.40
5.68%
0.29
시간 외 거래:
5.40
전일 마감가:
$5.11
열려 있는:
$4.93
하루 거래량:
23,467
Relative Volume:
0.32
시가총액:
$2.90M
수익:
-
순이익/손실:
$-8.82M
주가수익비율:
-0.00781
EPS:
-691.4213
순현금흐름:
$-8.08M
1주 성능:
+5.88%
1개월 성능:
-16.60%
6개월 성능:
-95.37%
1년 성능:
-99.70%
1일 변동 폭
$4.93
$5.51
1주일 범위
$4.68
$5.51
52주 변동 폭
$4.01
$2,240.00
Endra Life Sciences Inc Stock (NDRA) Company Profile
명칭
Endra Life Sciences Inc
전화
734-335-0468
주소
3600 GREEN COURT, ANN ARBOR, MI
NDRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.40 | 2.90M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
572.71 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.01 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.64 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
209.96 | 38.11B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
460.56 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
(NDRA) On The My Stocks Page - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
(NDRA) Trading Signals - Stock Traders Daily
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be presented at AASLD's The Liver Meeting 2024 - Marketscreener.com
Data I/O And 2 Other Stocks Under $5 Executives Are Buying - MSN
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
(NDRA) Technical Data - Stock Traders Daily
ENDRA Life Sciences Inc trading halted, volatility trading pause - TipRanks
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
ENDRA Life Sciences meets Nasdaq listing standards By Investing.com - Investing.com Australia
ENDRA Life Sciences meets Nasdaq listing standards - Investing.com
Endra Life Sciences regains compliance with Nasdaq - TipRanks
ENDRA Life Sciences Regains Nasdaq Compliance, Clears Path for Strategic Growth | NDRA Stock News - StockTitan
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartzy
ENDRA Life Sciences Reports Q3 2024 Results and Progress - TipRanks
Post Holdings beats Q4 estimates, issues fiscal 2025 outlook - Investing.com
ENDRA Life Sciences Cuts Operating Costs 52%, Accelerates Clinical Trial Progress | NDRA Stock News - StockTitan
NDRA stock touches 52-week low at $5.23 amid sharp annual decline - Investing.com
500: Something went wrong - Investing.com India
ENDRA's TAEUS Breakthrough: Liver Fat Detection in High-BMI Patients Validated for AASLD 2024 | NDRA Stock News - StockTitan
U.S. Stock market: Wolfspeed, ENDRA Life Sciences, and Clear Secure see significant declines with Wolfspeed down 32.10% - Business Upturn
U.S. Stock market: Cardlytics(- 30%0, CommScope (-26%) and Wolfspeed (-5%) among top losers as the market opens - Business Upturn
Turkey hopes for lower US tariffs under Trump, lira rallies - Investing.com
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent - The Bakersfield Californian
ENDRA Life Sciences Secures 17th EU Patent for Revolutionary Surgical Technology | NDRA Stock News - StockTitan
ENDRA Life Sciences announces reverse stock split - Investing.com India
ENDRA Life Sciences announces reverse stock split By Investing.com - Investing.com UK
AWH Stock Plummets 6.19% Amid Weak Financial Performance - GuruFocus.com
3 Penny Stocks to Watch Now, 10/24/24 - TipRanks
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Why ENDRA Life Sciences (NDRA) Stock Is Up 140% - Benzinga
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - The Bakersfield Californian
Market Momentum Report: ENDRA Life Sciences Inc (NDRA)’s Negative Close at 0.21 - The Dwinnex
Examining ENDRA Life Sciences Inc (NDRA) stock is warranted - US Post News
Investor optimism sees biggest jump since June 2020, survey shows By Reuters - Investing.com
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Stock Market Dynamics - The InvestChronicle
The growth track for ENDRA Life Sciences Inc (NDRA) has changed recently - SETE News
ENDRA Life Sciences Inc’s latest rating changes from various analysts - Knox Daily
Should investors be concerned about NDRA’s high price-to-sales ratio? - US Post News
Stock Market Recap: ENDRA Life Sciences Inc (NDRA) Concludes at 0.19, a -4.83 Surge/Decline - The Dwinnex
Digital Realty Trust Inc [DLR] stock was sold by MANDEVILLE JEAN F H P at the price of US$90156.0 - Knox Daily
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Adversity is less terrifying than hope: ENDRA Life Sciences Inc (NDRA) - SETE News
ENDRA Life Sciences Inc (NDRA)’s Day in Review: Closing at 0.20, Down by -3.13 - The Dwinnex
ENDRA Life Sciences Inc (NDRA) is a good investment, but the stock may be overvalued - US Post News
A company insider recently sold 139,357 shares of Nuzee Inc [NUZE]. Should You Sale? - Knox Daily
The time has not yet come to remove your chips from the table: ENDRA Life Sciences Inc (NDRA) - SETE News
Endra Life Sciences Inc (NDRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
자본화:
|
볼륨(24시간):